Literature DB >> 290036

The clinical diagnosis of the Zollinger-Ellison syndrome.

J G Stage, F Stadil.   

Abstract

Recent clinical experiences with 34 Z-E patients indicates that the clinical features and course of the syndrome is less dramatic than described originally. Eighty-five per cent of the patients presented stories of abdominal complaints lasting more than five years and resembling the complaints presented by duodenal ulcer patients (DU). Ulcers were present in 91 per cent of the patients. Fifty-one per cent had either ectopic or multiple ulcers. One third had a single duodenal ulcer resembling an ordinary ulcer. No patients died from complications to the ulcer diathesis. Marked hypersecretion of acid and gastrin was present in the ZE group (BAO:33.7 +/- 7.4; PAO:62.8 +/- 6.1 meq H+/h; gastrin: 5094 pmol/l), but because of great individual variation in the ZE, some overlapping with the acid and gastrin measurements of the DU was seen. The diagnostic value of provocative tests using secretin, calcium, glucagon and food stimulations demonstrated a considerable overlapping between the two groups, indicating that these tests are of little clinical value. Tumours were found in half the patients, revealing malignancy in ten. The ZE can be diagnosed in most cases by combining symptomatology, with measurements of acid and gastrin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 290036

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  16 in total

1.  Repeated vomiting of gastric juice in a patient with Zollinger-Ellison syndrome. Modifying influence upon clinical features.

Authors:  M Mignon; A Bonnefond; J Gratton; S Bonfils
Journal:  Dig Dis Sci       Date:  1981-08       Impact factor: 3.199

Review 2.  Zollinger-Ellison syndrome: classical considerations and current controversies.

Authors:  Irene Epelboym; Haggi Mazeh
Journal:  Oncologist       Date:  2013-12-06

3.  Weight Gain in Zollinger-Ellison Syndrome After Acid Suppression.

Authors:  Brian P Riff; David A Leiman; Bonita Bennett; Douglas L Fraker; David C Metz
Journal:  Pancreas       Date:  2016-02       Impact factor: 3.327

Review 4.  Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.

Authors:  Paola Tomassetti; Teresa Salomone; Marina Migliori; Davide Campana; Roberto Corinaldesi
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Gastrinoma excision for cure. A prospective analysis.

Authors:  T J Howard; M J Zinner; B E Stabile; E Passaro
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

6.  Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings.

Authors:  M Feldman; C T Richardson; J H Walsh
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

7.  Comparison of four provocative tests for the diagnosis of gastrinoma.

Authors:  M E Romanus; J A Neal; W G Dilley; G S Leight; W M Linehan; R J Santen; J R Farndon; R S Jones; S A Wells
Journal:  Ann Surg       Date:  1983-05       Impact factor: 12.969

Review 8.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

Review 9.  Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Authors:  P E Battershill; S P Clissold
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

Review 10.  Current diagnosis and management of Zollinger-Ellison syndrome.

Authors:  D K Andersen
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.